Your browser doesn't support javascript.
loading
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors.
Pant, S; Saleh, M; Bendell, J; Infante, J R; Jones, S; Kurkjian, C D; Moore, K M; Kazakin, J; Abbadessa, G; Wang, Y; Chen, Y; Schwartz, B; Camacho, L H.
Afiliación
  • Pant S; University of Oklahoma Health Sciences Center, Oklahoma City. Electronic address: shubham-pant@ouhsc.edu.
  • Saleh M; Georgia Cancer Specialists, Atlanta.
  • Bendell J; SCRI, Tennessee Oncology, PLLC, Nashville.
  • Infante JR; SCRI, Tennessee Oncology, PLLC, Nashville.
  • Jones S; SCRI, Tennessee Oncology, PLLC, Nashville.
  • Kurkjian CD; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Moore KM; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Kazakin J; Arqule, Inc., Woburn.
  • Abbadessa G; Arqule, Inc., Woburn.
  • Wang Y; Arqule, Inc., Woburn.
  • Chen Y; BioMarin Pharmaceutical, Inc., Novato.
  • Schwartz B; Arqule, Inc., Woburn.
  • Camacho LH; St Luke's Medical Center, Houston, USA.
Ann Oncol ; 25(7): 1416-1421, 2014 Jul.
Article en En | MEDLINE | ID: mdl-24737778
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas c-met / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas c-met / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article